Close to 80% of payers now prefer implementing vendor-built artificial intelligence (AI) tools rather than deploying internal capabilities, a...Read More »
More than half of patients with previously treated non-muscle invasive bladder cancer (NMIBC) had complete responses (CR) with an intravesical...Read More »